Entera Bio Ltd.

Ownership Transactions Reported by 16 Insiders

Symbol
ENTX on Nasdaq
Location
Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, Israel

Insiders trading volume in the past year

Entera Bio Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Phillip Schwartz President of R&D, Director $601K Jan 20, 2022
Gerald M. Lieberman Director $231K Oct 2, 2024
Miranda Jayne Toledano Chief Executive Officer, Director $110K Jul 31, 2024
Dana Yaacov-Garbeli Chief Financial Officer $85.9K Apr 19, 2024
Gregory Burshtein Chief of R&D $74.4K May 28, 2024
Hillel Galitzer Chief Operating Officer $63.6K Apr 19, 2024
Haya Taitel Director $34.8K +$15.3K +78.3% Oct 2, 2024
Spiros Jamas Chief Executive Officer $9.9K Jan 18, 2022
Ramesh Ratan U.S.based CFO $9.9K Jan 19, 2022
Arthur C. Santora II Chief Medical Officer Apr 24, 2023
Ron Mayron Director Jan 1, 2024
Gerald M. Ostrov Director Oct 2, 2024
Roger Garceau Director Jan 1, 2024
Sean Ellis Director Oct 2, 2024
Knoll Capital Management, LLC 10%+ Owner Nov 14, 2024
Yonatan Malca Director Oct 2, 2024

Recent Insider Transactions by Companies or Individuals for Entera Bio Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.